Chronic kidney disease in adolescent and adult patients with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 36, Issue 5, 2013, Pages 747-756

  Hennermann, Julia B ^a   Roloff, Sylvia ^a   Gellermann, Jutta ^a   Vollmer, Ilka ^a   Windt, Elke ^a   Vetter, Barbara ^a   Plöckinger, Ursula ^a   Mönch, Eberhard ^a   Querfeld, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; PHENYLALANINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOGRAPHY; FEMALE; GENE MUTATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PHENYLKETONURIA; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN DIET; PROTEIN INTAKE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIET, PROTEIN-RESTRICTED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; PHENYLKETONURIAS; PROTEINURIA; RENAL CIRCULATION; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84884350808     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9548-0     Document Type: Article

References (52)

1. Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenylketonuria. Eur J Pediatr 155(Suppl 1):S121-S124
2. Acosta PB, Yannicelli S, Marriage B, et al. (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287-291
3. Acosta PB, Yanicelli S, Singh R, et al. (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103:1167-1173
4. Anderson PH, O'Loughlin PD, May BK, Morris HA (2004) Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 89-90:111-113
5. Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, Deluca JM (2002) Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 141:243-246
6. Bernstein AM, Treyzon L, Li Z (2007) Are high-protein, vegetable based diets safe for kidney function? A review of the literature. J Am Diet Assoc 107:644-650
7. Blecker S, Matsushita K, Köttgen A, et al. (2011) High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis 58:47-55
8. Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307:652-659
9. Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774-1777
10. Burgard P, Bremer HJ, Bührdel P, et al. (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158:46-54
11. Chaturvedi S, Jones C (2007) Protein restriction for children with chronic renal failure. Cochrane Database Syst Rev 17(4):CD006863
12. DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1985) Empfehlungen für die Nährstoffzufuhr: Umschau Verlag
13. DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1991) Empfehlungen für die Nährstoffzufuhr: Umschau/Braus
14. D-A-CH Empfehlung: Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2000) Referenzwerte für die Nährstoffzufuhr: Umschau/Braus
15. Enomoto A, Niwa T (2007) Roles of organic anion transporters in the progression of chronic renal failure. Ther Apher Dial 11(Suppl 1):S27-S31
16. Fouque D, Aparicio M (2007) Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol 3:383-392
17. German Nutrition Society (2012) New reference values for vitamin D. Ann Nutr Metab 60:241-246
18. Gropper SS, Gropper DM, Acosta PB (1993) Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr 16:143-150
19. Guldberg P, Rey F, Zschocke J, et al. (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71-79
20. Güttler F, Guldberg KF (1994) Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia. Acta Paediatr 407(Suppl):46-56
21. Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP (2009) Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 46:468-476
22. Halbesma N, Bakker SJ, Jansen DF, et al. (2009) High protein intake associates with cardiovascular events but not with loss of renal function. J Am Soc Nephrol 20:1797-1804
23. Hennermann JB, Vetter B, Wolf C, et al. (2000) Phenylketonuria and hyperphenylalaninemia in Eastern Germany: a characteristic molecular profile and 15 novel mutations. Hum Mut 15:254-260
24. Hoeksma M, Van Rijn M, Verkerk PH, et al. (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28:845-854
25. Hüseman D, Gellermann J, Vollmer I, et al. (1999) Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13:672-677
26. Itoh R, Nishiyama N, Suyama Y (1998) Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population. Am J Clin Nutr 67:438-444
27. Jia Y, Hwang SY, House JD, Ogborn MR, Weiler HA, Karmin O, Aukema HM (2010) Long-term high intake of whole proteins results in renal damage in pigs. J Nutr 140: 1646-1652
28. Kambham N, Markowitz GS, Valeri AM (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498-1509
29. Kastarinen H, Vasunta RL, Ukkola O, Kesäniemi YA (2010) Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring - a cross-sectional population-based study. J Hum Hypertens 24:247-253
30. King AJ, Levey AS (1993) Dietary protein and renal function. J Am Soc Nephrol 3:1723-1737
31. Kooman JP (2009) Estimation of renal function in patients with chronic kidney disease. J Magn Reson Imaging 30:1341-1346
32. Krauch G, Müller E, Anninos A, Bremer HJ (1996) Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO expert consultation. Eur J Pediatr 155(Suppl 1):S153-S157
33. Kriz W (2004) Podocytes as a target for treatment with ACE inihibitors and/or angiotensin-receptor blockers. Kidney Int 65:333-334
34. Lichter-Konecki U, Hipke CM, Konecki DS (1999) Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Mol Genet Metab 67:308-316
35. MacDonald A, Rocha JC, van Rijn M, Feillet F (2011) Nutrition in phenylketonuria. Mol Genet Metab 104(Suppl):S10-S18
36. Manz F, Schmidt H, Schärer K, Bickel H (1977) Acid-base status in dietary treatment of phenylketonuria. Pediatr Res 11:1084-1087
37. Mönch E, Herrmann ME, Brösicke H, Schöffer A, Keller M (1996) Utilisation of amino acid mixtures in adolescents with phenylketonuria. Eur J Pediatr 155(Suppl 1):S115-S120
38. O'Brien E, Asmar R, Beilin L, et al. (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697-701
39. Parati G, Pickering TG (2009) Home blood-pressure monitoring: US and European consensus. Lancet 373:876-878
40. Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653-662
41. Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77-83
42. Schwartz GJ, Muñoz A, Schneider MF, et al. (2009) New equations to estimate GFR in children with CKAD. J Am Soc Nephrol 20:629-637
43. Scriver CR, Kaufman S (2001) Phenylalanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly W, Valle D, Childs B, Vogelstein B (eds). The metabolic and molecular basis of inherited disease. McGraw-Hill, 1667-1724
44. Sirtori LR, Dutra-Filho CS, Fitarelli D, et al. (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68-73
45. Sitta A, Barschak AG, Deon M, et al. (2009) L-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211-218
46. Staples A, LeBlond R, Watkins S, Wong C, Brandt J (2010) Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol 25:2321-2326
47. White JE, Kronmal RA, Acosta PB (1982) Excess weight among children with phenylketonuria. J Am Coll Nutr 1:293-303
48. Wingen AM, Fabian-Bach C, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European study group of nutritional treatment of chronic renal failure in childhood. Lancet 349:1117-1123
49. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) German working group on pediatric hypertension: distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995-2007
50. Zager RA, Johannes G, Tuttle SE, Sharma HM (1983) Acute amino acid nephrotoxicity. J Lab Clin Med 101:130-140
51. Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Publ Health 8:117
52. Zhao YY, Liu J, Cheng XL, Bai X, Lin RC (2012) Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413:642-649